ALPS Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $95K | Sell |
|
|||||
|
2022
Q2 | $163K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $985K | Sell |
|
|||||
|
2021
Q2 | $872K | Sell |
|
|||||
|
2021
Q1 | $1.49M | Buy |
|
|||||
|
2020
Q4 | $1.51M | Buy |
|
|||||
|
2020
Q3 | $1.57M | Sell |
|
|||||
|
2020
Q2 | $2.06M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $1.41M | Buy |
|
|||||
|
2017
Q4 | $693K | Buy |
|
|||||
|
2017
Q3 | $754K | Buy |
|
|||||
|
2017
Q2 | $287K | Buy |
|
|||||
|
2017
Q1 | $336K | Sell |
|
|||||
|
2016
Q4 | $275K | Buy |
|